Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLivermore Regulatory News (LIV)

Share Price Information for Livermore (LIV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.00
Bid: 28.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.143%)
Open: 29.00
High: 0.00
Low: 0.00
Prev. Close: 29.00
LIV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 update

9 Apr 2020 07:00

RNS Number : 2823J
Livermore Investments Group Limited
09 April 2020
 

9 April 2020

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

LIVERMORE INVESTMENTS GROUP LIMITED

 

("Livermore" or the "Company")

 

COVID-19 Update

 

 

Livermore today provides a statement on the impact of COVID-19.

The Company continues to monitor the COVID-19 pandemic situation closely, with a focus on the impact on the Company's CLO and US senior secured loan portfolios. The spread of the virus, government policy responses and changing demand patterns are expected to have a negative impact on the operations and earnings of some of the borrowers in the CLO portfolio. The Company has been in close contact with managers of its individual CLO positions and is tracking the level of rating downgrades of underlying loans to CCC+/Caa rating and a worsening default outlook. A significant concentration of CCC+/Caa rated loans can turn off the distributions to the equity and lower mezzanine tranches of CLOs and would result in significant drop in the market values of those CLO portfolio constituents. At this early stage it is not possible to quantify the impact, but further updates will be provided as more information becomes available. The full extent of the impact will depend on the length and severity of the crisis and is expected to vary widely between sectors and companies.

The Company has been positioned very conservatively for several months with high liquidity and cash reserves (in excess of USD 60m as of 31 March 2020) and a CLO portfolio that consists largely of CLOs with long reinvestment periods, which should benefit somewhat from the volatility in the market. The Company has no debt.

Looking forward, the Company believes it is very well positioned with its large cash reserves to capitalize on a recovery in trade in the CLO markets when there is more clarity on positive developments in the US economy and the US credit markets.

 

 

Enquiries:

 

Livermore Investments Group Limited

 +41 43 344 3200

Gaurav Suri

 

 

Nominated Broker and Adviser

Arden Partners

Richard Johnson

 

+44 207 614 5917

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDVLFBBZLBBBX
Date   Source Headline
8th May 200810:25 amRNSSubstantial Shareholdings
7th May 20089:12 amRNSTransaction in Own Shares
6th May 20088:00 amRNSDividend Timetable
2nd May 20087:01 amRNSFinal Results
29th Apr 20084:18 pmRNSUpdate re: Timing of Prelims
1st Apr 20087:01 amRNSTrading Statement
7th Mar 20084:35 pmRNSPrice Monitoring Extension
6th Feb 20085:50 pmRNSUSD 20 Million Investment
30th Jan 20084:49 pmRNSTransaction in Own Shares
25th Jan 20086:07 pmRNSTransaction in Own Shares
23rd Jan 20088:53 amRNSTransaction in Own Shares
3rd Jan 20083:24 pmRNSDirector/PDMR Shareholding
31st Dec 20079:38 amRNSIncreasing Holdings in Atlas
24th Dec 20079:36 amRNSDirector/PDMR Shareholding
24th Dec 20079:32 amRNSDirector/PDMR Shareholding
18th Dec 200712:07 pmRNSDirector/PDMR Shareholding
17th Dec 20078:58 amRNSDirector/PDMR Shareholding
14th Dec 20071:21 pmRNSHolding(s) in Company
13th Dec 20079:05 amRNSDirector/PDMR Shareholding
12th Dec 20076:13 pmRNSAcquisition of Shares
12th Dec 20079:11 amRNSDirector/PDMR Shareholding
12th Dec 20079:10 amRNSDirector/PDMR Shareholding
7th Dec 20077:01 amRNSSignificant Share Position
31st Oct 20078:37 amRNSInvestment in DTH
18th Oct 20079:27 amRNSDirector/PDMR Shareholding
2nd Oct 20078:02 amRNSDirector/PDMR Shareholding
24th Sep 20077:02 amRNSInterim Results
20th Aug 200711:55 amRNSre: AIM Rule 26
10th Aug 20079:19 amRNSBoard Change
3rd Jul 20078:00 amRNSAcquisition
28th Jun 20077:02 amRNSHolding(s) in Company
27th Jun 200712:30 pmRNSDirectorate Change
14th Jun 20072:45 pmRNSHolding(s) in Company
8th Jun 20077:01 amRNSHolding(s) in Company
5th Jun 200712:32 pmRNSHolding(s) in Company
30th May 20075:44 pmRNSDirector/PDMR Shareholding
21st May 20075:19 pmRNSTrans. in Own Shares - Amend
15th May 200711:22 amRNSAGM Statement
10th May 20079:56 amRNSDirector/PDMR Shareholding
30th Apr 20075:10 pmRNSTransaction in Own Shares
3rd Apr 200712:01 pmRNSDividend record date
3rd Apr 20077:23 amRNSDirector/PDMR Shareholding
2nd Apr 20077:01 amRNSFinal Results
20th Mar 20073:42 pmRNSEmpire Online Name Change
28th Feb 200711:31 amRNSResult of EGM
6th Feb 20077:01 amRNSCircular and Notice of EGM
19th Jan 20073:33 pmRNSCompletion of sale
19th Jan 200711:01 amRNSCompletion of Acquisition
17th Jan 20071:49 pmRNSResult of EGM
16th Jan 20077:01 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.